OUTCOMES AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY FOR MORBIDLY OBESE PATIENTS

Introduction: laparoscopic Sleeve gastrectomy has become reportedly one of the most effective standalone bariatric procedures during the past decade. The intermediate and long-term outcomes are being studied by many researchers.
Aim: To study the short and intermediate term results of LSG in a group of Egyptian morbidly obese patients as regards mean decrease in body mass index (BMI), % of excessive weight loss (% EWL), and resolution of comorbidities.
Results: One hundred and forty patients, 92 females (66%) and 48 males (34%), with a mean BMI of 49 ± 7.4 kg/m2 contributed in our study. Obesity related comorbidities were reported in some of our patients in the form of Type II diabetes mellitus (n=43), hypertension (n=36), hyperlipidemia (n=24), and osteoarthritis (n=30). All patients underwent laparoscopic sleeve gastrectomy. All patients completed a follow up period of two years. At two years period the mean BMI decreased to 30 ± 5.9 kg/m2 (p-value < 0.0001). While the mean % of EWL was 73 ± 10.3 %. We reported complete resolution of disease in 90.6%, 94.4%, and 83.3% of Type II diabetes mellitus, hypertension, and hyperlipidemia patients respectively.
Conclusion: laparoscopic sleeve gastrectomy is associated with significant decrease in mean BMI, and % of EWL in morbidly obese patients during the short and intermediate terms. In addition, it is associated with resolution of obesity related comorbidities in high percentage of patients.